Nigel Ten Fleming

Nigel Ten Fleming is the founder of BioVision, Inc. (founded in 1996) and Genica Pharmaceuticals Corp.
(founded in 1989).
He also founded Minoryx Therapeutics SL in 2011.
Dr. Fleming is currently the Chairman & Chief Executive Officer at Minerva Healthcare, Inc. since 2008.
Dr. Fleming has held various former positions including Director-Business Development at Athena Neurosciences LLC, Independent Director at Impax Laboratories LLC (2011-2016), Director-Business Development at Elan Pharmaceuticals, LLC, Director at Examplar (1992-1994), Director at Genmedica Therapeutics SL (2005-2012), Director at PATH Drug Solutions, Director at A-CUBE, Inc. (2011-2012), Director at Serenus Biotherapeutics, Inc. (2014-2016), and Lecturer at Harvard University.
Dr. Fleming has a doctorate degree from the University of Cambridge, an undergraduate degree from The University of North Carolina at Chapel Hill, and a doctorate degree from Boston University School of Medicine.
Dr. Fleming is also the founder of Blueprint Genetics, Inc., G2B Pharma, Inc., Adventura Capital SL.